Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V-Nathan Subramaniam

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|March 20, 2004
Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosisDaniel F Wallace, Roslyn M Clark, Hugh A J Harley, et al.
Journal of Gastroenterology and Hepatology|April 13, 2013
Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutationsCameron J McDonald, Daniel F Wallace, Darrell H G Crawford, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|April 29, 2021
In vitro identification and characterisation of iron chelating catechol-containing natural products and derivativesZachary J Hawula, Rohan A Davis, Daniel F Wallace, et al.
Bioscience Reports|June 22, 2021
The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overloadZachary J Hawula, Eriza S Secondes, Daniel F Wallace, et al.
Genesis (New York, N.Y. : 2000)|May 5, 2004
Inactivation of the murine Transferrin Receptor 2 gene using the Cre recombinase: loxP systemDaniel F Wallace, Ian D Tonks, Anna Zournazi, et al.
World Journal of Gastroenterology|January 11, 2014
Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosisMarnie J Wood, Lawrie W Powell, Jeannette L Dixon, et al.
American Journal of Hematology|July 7, 2017
The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutationDaniel F Wallace, Cameron J McDonald, Lesa Ostini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 23, 2020
Hepatocyte-specific deletion of peroxisomal protein PEX13 results in disrupted iron homeostasisGautam Rishi, Maneet Bhatia, Eriza S Secondes, et al.
Journal of Hepatology|November 25, 2010
G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defectiveCameron J McDonald, Daniel F Wallace, Lesa Ostini, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Carrier-mediated thyroid hormone transport into placenta by placental transthyretinKelly A Landers, Brett D McKinnon, Huika Li, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|March 20, 2004
Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosisDaniel F Wallace, Roslyn M Clark, Hugh A J Harley, et al.
Journal of Gastroenterology and Hepatology|April 13, 2013
Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutationsCameron J McDonald, Daniel F Wallace, Darrell H G Crawford, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|April 29, 2021
In vitro identification and characterisation of iron chelating catechol-containing natural products and derivativesZachary J Hawula, Rohan A Davis, Daniel F Wallace, et al.
Bioscience Reports|June 22, 2021
The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overloadZachary J Hawula, Eriza S Secondes, Daniel F Wallace, et al.
Genesis (New York, N.Y. : 2000)|May 5, 2004
Inactivation of the murine Transferrin Receptor 2 gene using the Cre recombinase: loxP systemDaniel F Wallace, Ian D Tonks, Anna Zournazi, et al.
World Journal of Gastroenterology|January 11, 2014
Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosisMarnie J Wood, Lawrie W Powell, Jeannette L Dixon, et al.
American Journal of Hematology|July 7, 2017
The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutationDaniel F Wallace, Cameron J McDonald, Lesa Ostini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 23, 2020
Hepatocyte-specific deletion of peroxisomal protein PEX13 results in disrupted iron homeostasisGautam Rishi, Maneet Bhatia, Eriza S Secondes, et al.
Journal of Hepatology|November 25, 2010
G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defectiveCameron J McDonald, Daniel F Wallace, Lesa Ostini, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2009
Carrier-mediated thyroid hormone transport into placenta by placental transthyretinKelly A Landers, Brett D McKinnon, Huika Li, et al.
Pageof 9